The TMB level that was observed in the present study (median 3.36/Mb) was much lower than that which was observed in previous studies on unselective NSCLC [20,21] but was comparable to those of previous studies that reported low TMB levels in EGFR-mutant tumors [19,22]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.